Intravenous high-dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine

Pain

Volumn 73, Issue 2, 1997, Pages 259-261

  Fitzgibbon, Dermot R ^a   Ready, L Brian ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Analgeisa; Cancer pain; Methadone; Morphine

Indexed keywords

METHADONE; MORPHINE;

ADULT; ARTICLE; CANCER PAIN; CASE REPORT; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL;

ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; TREATMENT OUTCOME;

EID: 0030727338     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00118-8     Document Type: Article

References (18)

1. Agency for Health Care Policy and Research, Management of Cancer Pain. A Clinical Practice Guideline, US Department of Health and Human Devices, 1994.
2. Bruera E., Pereira J., Watanabe S., Belzile M., Kuehn N., Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer. 78:1996;852-857.
3. Cherny N.I., Portenoy R.K. Cancer pain management. Current strategy. Cancer. 72:1993;3393-3415.
4. Cleeland C.S., Gonin R., Hatfield A.K., Edmonson J.H., Blum R.H., Stewart J.A., Pandya K.J. Pain and its treatment in outpatients with metastatic cancer. N. Engl. J. Med. 330:1994;592-596.
5. Crews J.C., Sweeney N.J., Denson D.D. Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics. Cancer. 72:1993;2266-2272.
6. Ettinger D.S., Vitale P.J., Trump D.L. Important clinical pharmacologic considerations in the use of methadone in cancer patients. Cancer Treat. Rep. 63:1979;457-459.
7. Fainsinger R., Schoeller T., Bruera E. Methadone in the management of cancer pain: a review. Pain. 52:1993;137-147.
8. Foley, K.M., Pharmacologic approaches to cancer pain management. In: H.L. Fields, R. Dubner and R. Cervero (Eds.), Proceedings of the Fourth World Congress on Pain: Advances in Pain Research and Therapy, Vol. 9, Raven Press, New York, 1985, pp. 629-653.
9. Galer B.S., Coyle N., Pasternak G.W., Portenoy R.K. Individual variability in the response to different opioids: report of five cases. Pain. 49:1992;87-91.
10. Gorman A.L., Elliott K.J., Inturrisi C.E. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223:1997;5-8.
11. Hug C.C. Jr., Murphy M.R., Rigel E.P., Olson W.A. Pharmacokinetics of morphine injected intravenously into the anesthetized dog. Anesthesiology. 54:1981;38-47.
12. Inturrisi C.E., Colburn W.A., Kaiko R.F., Houde R.W., Foley K.M. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin. Pharmacol. Ther. 41:1987;392-401.
13. Ivarsson M., Neil A. Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol. Toxicol. 65:1989;368-371.
14. MacDonald N., Der L., Allan S., Champion P. Opioid hyperexcitability: the application of alternate opioid therapy. Pain. 53:1993;353-355.
15. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
16. Moulin D.E., Ling G.S., Pasternak G.W. Unidirectional analgesic cross-tolerance between morphine and levorphanol in the rat. Pain. 33:1988;233-239.
17. Sawe J., Hansen J., Ginman C., Hartvig P., Jakobsson P.A., Nilsson M.I., Rane A., Anggard E. Patient-controlled dose regimen of methadone for chronic cancer pain. Br. Med. J. 282:1981;771-773.
18. World Health Organization, Cancer Pain Relief and Palliative Care. Technical Report Series, 804, Geneva, 1990.